Henry Nordhoff
Chief Executive Officer chez Banyan Biomarkers, Inc.
Profil
Henry L.
Nordhoff is currently the Chairman & Chief Executive Officer at Banyan Biomarkers, Inc. He is also the Chairman at Chugai Pharma USA LLC, Chairman at Proactive Diagnostics, and a Trustee at Sanford Burnham Prebys Medical Discovery Institute.
Previously, he was the President & Chief Executive Officer at Targetech, Inc. and the Non-Executive Chairman at Gen-Probe, Inc. He also served as the Executive Chairman at Cypher Genomics, Inc. and as an Independent Director at Lineage Cell Therapeutics, Inc., MannKind Corp., and Asterias Biotherapeutics, Inc. Additionally, he was the Managing Director at Shipston Group Ltd.
Nordhoff holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Johns Hopkins University.
Postes actifs de Henry Nordhoff
Sociétés | Poste | Début |
---|---|---|
Proactive Diagnostics
Proactive Diagnostics Medical SpecialtiesHealth Technology Proactive Diagnostics manufactures medical devices. It develops optical platform for molecular diagnostics. Its platform employs the Planar Lightwave Circuits technology that uses semiconductor manufacturing processes to create waveguide-based optical chips. The company was founded by Reuven Duer and James N. Herron in 2006 and is headquartered in Thousand Oaks, CA. | Chairman | 16/05/2011 |
Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Director/Board Member | - |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Chairman | 01/01/2013 |
Anciens postes connus de Henry Nordhoff
Sociétés | Poste | Fin |
---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Director/Board Member | 10/04/2014 |
LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 07/04/2014 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Chief Executive Officer | 17/05/2009 |
Cypher Genomics, Inc.
Cypher Genomics, Inc. Information Technology ServicesTechnology Services Cypher Genomics, Inc. provides automated human genome interpretation software solutions. It offers molecular diagnostics, drug development, and science and technology. The company was founded by Ashley Van Zeeland and Ali Torkamani in 2011 and is headquartered in San Diego, CA. | Chairman | - |
Shipston Group Ltd.
Shipston Group Ltd. Investment ManagersFinance Shipston Group Ltd (Shipston Group) is a private equity firm founded in 1996 by Michael D. Dingman. The firm is headquartered in Lyford Cay, Bahamas. | Private Equity Investor | - |
Formation de Henry Nordhoff
The Trustees of Columbia University in The City of New York | Masters Business Admin |
The Johns Hopkins University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
MANNKIND CORPORATION | Health Technology |
Entreprise privées | 9 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Targetech, Inc.
Targetech, Inc. Miscellaneous Commercial ServicesCommercial Services TargeTech, Inc., is a gene therapy company. Develops drug delivery systems. | Commercial Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Distribution Services |
Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Health Services |
Proactive Diagnostics
Proactive Diagnostics Medical SpecialtiesHealth Technology Proactive Diagnostics manufactures medical devices. It develops optical platform for molecular diagnostics. Its platform employs the Planar Lightwave Circuits technology that uses semiconductor manufacturing processes to create waveguide-based optical chips. The company was founded by Reuven Duer and James N. Herron in 2006 and is headquartered in Thousand Oaks, CA. | Health Technology |
Shipston Group Ltd.
Shipston Group Ltd. Investment ManagersFinance Shipston Group Ltd (Shipston Group) is a private equity firm founded in 1996 by Michael D. Dingman. The firm is headquartered in Lyford Cay, Bahamas. | Finance |
Cypher Genomics, Inc.
Cypher Genomics, Inc. Information Technology ServicesTechnology Services Cypher Genomics, Inc. provides automated human genome interpretation software solutions. It offers molecular diagnostics, drug development, and science and technology. The company was founded by Ashley Van Zeeland and Ali Torkamani in 2011 and is headquartered in San Diego, CA. | Technology Services |